Integrating single‑cell transcriptomics and machine‑learning model screening to identify a KIAA0408‑associated B‑cell prognostic signature in ovarian cancer

Ovarian cancer is the most lethal gynecologic malignancy, with most patients exhibiting suboptimal responses to T cell-targeted immune checkpoint inhibitors. Despite increasing attention to B cells in tumor immunity, the role of tumor-infiltrating B cells in ovarian cancer remains incompletely elucidated. Using single-cell RNA sequencing data, we constructed a high-resolution cellular atlas of the high-grade serous ovarian cancer, integrating inferCNV, CytoTRACE, and hdWGCNA to systematically analyze B cell copy number variations, differentiation trajectories, and co-expression networks. A machine learning-derived prognostic risk model was evaluated across multiple cohorts. The immune microenvironment was computationally profiled with ESTIMATE and immune deconvolution. KIAA0408‑related phenotypes were assessed by flow cytometry, immunoblotting, cell‑cycle, colony‑formation and CCK‑8 assays. Drug candidates were screened in databases and validated experimentally. Single-cell sequencing reveals ovarian cancer B cell heterogeneity, aberrant T-cell crosstalk, and KIAA0408 as a core regulator. The model of KIAA0408, CEACAM8, CAPZA1, PTCH1 and VPS13A showed prognostic stratification, pending validation in independent cohorts. High-risk patients exhibited an “ineffective inflammation” phenotype, featuring myeloid-derived suppressor cell-predominant infiltration, insufficient memory T cells, and impaired anti-tumor immunity. Mechanistically, KIAA0408 overexpression correlated with suppressed BCR‑AKT signaling and altered B‑cell‑cycle and conditioned‑medium phenotypes. Isoliquiritigenin showed antiproliferative effects, which may be linked to modulation of this pathway. This study reveals KIAA0408-mediated B-cell immune regulation in ovarian cancer, proposes a multi-gene prognostic model pending independent validation, and identifies isoliquiritigenin as a potential therapeutic agent.

Authors

Institutions

Publication Details

Journal
Journal of Ovarian Research
Published
2026-11-21
DOI
https://doi.org/10.1186/s13048-026-02352-y
Primary Topic
Ovarian cancer diagnosis and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Integrating single‑cell transcriptomics and machine‑learning model screening to identify a KIAA0408‑associated B‑cell prognostic signature in ovarian cancer

Z M Liu, X Wang, Yanying Zhong, Ye Zhu et al.
5 links
Journal of Ovarian Research
Ovarian cancer diagnosis and treatment
article

Integrating single‑cell transcriptomics and machine‑learning model screening to identify a KIAA0408‑associated B‑cell prognostic signature in ovarian cancer

Z M Liu, X Wang, Yanying Zhong, Ye Zhu, Xiaoyu Qu, Ye Cao, Ruiyu Zhang, Ruida Shi, Chenshuo Fang, Hao Wan, Shengwei Tang, Mingyuan Bo, Kangcheng Wang, Haiyan Wang, Da Huang
article en

Abstract

Ovarian cancer is the most lethal gynecologic malignancy, with most patients exhibiting suboptimal responses to T cell-targeted immune checkpoint inhibitors. Despite increasing attention to B cells in tumor immunity, the role of tumor-infiltrating B cells in ovarian cancer remains incompletely elucidated. Using single-cell RNA sequencing data, we constructed a high-resolution cellular atlas of the high-grade serous ovarian cancer, integrating inferCNV, CytoTRACE, and hdWGCNA to systematically analyze B cell copy number variations, differentiation trajectories, and co-expression networks. A machine learning-derived prognostic risk model was evaluated across multiple cohorts. The immune microenvironment was computationally profiled with ESTIMATE and immune deconvolution. KIAA0408‑related phenotypes were assessed by flow cytometry, immunoblotting, cell‑cycle, colony‑formation and CCK‑8 assays. Drug candidates were screened in databases and validated experimentally. Single-cell sequencing reveals ovarian cancer B cell heterogeneity, aberrant T-cell crosstalk, and KIAA0408 as a core regulator. The model of KIAA0408, CEACAM8, CAPZA1, PTCH1 and VPS13A showed prognostic stratification, pending validation in independent cohorts. High-risk patients exhibited an “ineffective inflammation” phenotype, featuring myeloid-derived suppressor cell-predominant infiltration, insufficient memory T cells, and impaired anti-tumor immunity. Mechanistically, KIAA0408 overexpression correlated with suppressed BCR‑AKT signaling and altered B‑cell‑cycle and conditioned‑medium phenotypes. Isoliquiritigenin showed antiproliferative effects, which may be linked to modulation of this pathway. This study reveals KIAA0408-mediated B-cell immune regulation in ovarian cancer, proposes a multi-gene prognostic model pending independent validation, and identifies isoliquiritigenin as a potential therapeutic agent.

Journal of Ovarian Research
Nanchang University (CN), Second Affiliated Hospital of Nanchang University (CN), First Affiliated Hospital of Nanchang University (CN)
Good health and well-being
Ovarian cancer diagnosis and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon